Overview

Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effects of Eszopiclone, a sleep aid, on inflammatory mediators and coagulability in patients with a recent myocardial infarction.
Phase:
Phase 4
Details
Lead Sponsor:
University of Arizona
Collaborators:
Southern Arizona VA Health Care System
Sunovion
Treatments:
Eszopiclone